US Stock MarketDetailed Quotes

NBIX Neurocrine Biosciences

Watchlist
  • 152.810
  • +0.240+0.16%
Close Aug 23 16:00 ET
  • 152.810
  • 0.0000.00%
Post 20:02 ET
15.43BMarket Cap46.03P/E (TTM)

Neurocrine Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
30.37%590.2M
22.57%515.3M
26.76%1.89B
25.05%515.2M
28.59%498.8M
19.70%452.7M
35.35%420.4M
31.34%1.49B
32.05%412M
31.05%387.9M
Operating revenue
30.37%590.2M
22.57%515.3M
26.76%1.89B
25.05%515.2M
28.59%498.8M
19.70%452.7M
35.35%420.4M
31.34%1.49B
32.05%412M
31.05%387.9M
Cost of revenue
-20.00%9.2M
-11.76%7.5M
71.12%39.7M
10.39%8.5M
83.61%11.2M
139.58%11.5M
84.78%8.5M
62.24%23.2M
87.80%7.7M
45.24%6.1M
Gross profit
31.69%581M
23.28%507.8M
26.06%1.85B
25.33%506.7M
27.71%487.6M
18.16%441.2M
34.61%411.9M
30.94%1.47B
31.31%404.3M
30.84%381.8M
Operating expense
17.82%433.1M
5.31%402.5M
19.41%1.45B
18.44%356.4M
17.82%346.4M
15.34%367.6M
26.18%382.2M
33.48%1.22B
23.37%300.9M
18.88%294M
Selling and administrative expenses
9.11%242M
0.16%243.1M
17.92%887.6M
19.68%218.9M
9.61%204.2M
21.33%221.8M
20.93%242.7M
29.04%752.7M
16.87%182.9M
20.50%186.3M
Research and development costs
31.07%191.1M
14.27%159.4M
21.82%565M
16.53%137.5M
32.03%142.2M
7.28%145.8M
36.50%139.5M
41.36%463.8M
35.01%118M
16.18%107.7M
Operating profit
100.95%147.9M
254.55%105.3M
58.55%394.8M
45.36%150.3M
60.82%141.2M
34.55%73.6M
858.06%29.7M
19.83%249M
61.56%103.4M
97.30%87.8M
Net non-operating interest income expense
-49.7M
-8,063.64%-89.8M
35.21%-4.6M
0.00%-1.1M
8.33%-1.1M
0
57.69%-1.1M
72.48%-7.1M
83.33%-1.1M
81.82%-1.2M
Non-operating interest expense
--49.7M
8,063.64%89.8M
-35.21%4.6M
0.00%1.1M
-8.33%1.1M
--0
-57.69%1.1M
-72.48%7.1M
-83.33%1.1M
-81.82%1.2M
Other net income (expense)
-99.17%400K
114.40%19M
-107.50%-58.1M
214.10%49M
-316.81%-24.5M
163.32%48M
-731.10%-131.9M
65.26%-28M
121.91%15.6M
252.70%11.3M
Gain on sale of security
-93.96%2.9M
108.33%25M
104.29%85.8M
214.10%49M
-316.81%-24.5M
927.59%48M
-42.58%12M
70.04%42M
-46.39%15.6M
252.70%11.3M
Special income (charges)
---2.5M
95.83%-6M
-105.57%-143.9M
--0
--0
--0
---143.9M
33.52%-70M
--0
--0
-Less:Other special charges
--2.5M
-95.83%6M
105.57%143.9M
--0
----
----
--143.9M
-33.52%70M
--0
----
Income before tax
-18.91%98.6M
133.40%34.5M
55.26%332.1M
68.11%198.2M
18.08%115.6M
621.89%121.6M
-582.71%-103.3M
110.95%213.9M
954.35%117.9M
220.98%97.9M
Income tax
28.74%33.6M
66.67%-8.9M
38.72%82.4M
74.74%50.5M
10.54%32.5M
507.81%26.1M
-456.00%-26.7M
403.39%59.4M
544.62%28.9M
267.50%29.4M
Net income
-31.94%65M
156.66%43.4M
61.62%249.7M
65.96%147.7M
21.31%83.1M
665.09%95.5M
-651.08%-76.6M
72.43%154.5M
1,319.18%89M
204.44%68.5M
Net income continuous Operations
-31.94%65M
156.66%43.4M
61.62%249.7M
65.96%147.7M
21.31%83.1M
665.09%95.5M
-651.08%-76.6M
72.43%154.5M
1,319.18%89M
204.44%68.5M
Minority interest income
Net income attributable to the parent company
-31.94%65M
156.66%43.4M
61.62%249.7M
65.96%147.7M
21.31%83.1M
665.09%95.5M
-651.08%-76.6M
72.43%154.5M
1,319.18%89M
204.44%68.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-31.94%65M
156.66%43.4M
61.62%249.7M
65.96%147.7M
21.31%83.1M
665.09%95.5M
-651.08%-76.6M
72.43%154.5M
1,319.18%89M
204.44%68.5M
Basic earnings per share
-34.69%0.64
154.43%0.43
59.01%2.56
63.04%1.5
18.06%0.85
644.44%0.98
-626.67%-0.79
69.47%1.61
1,250.00%0.92
200.00%0.72
Diluted earnings per share
-33.68%0.63
153.16%0.42
58.33%2.47
63.64%1.44
18.84%0.82
627.78%0.95
-664.29%-0.79
69.57%1.56
1,200.00%0.88
200.00%0.69
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 30.37%590.2M22.57%515.3M26.76%1.89B25.05%515.2M28.59%498.8M19.70%452.7M35.35%420.4M31.34%1.49B32.05%412M31.05%387.9M
Operating revenue 30.37%590.2M22.57%515.3M26.76%1.89B25.05%515.2M28.59%498.8M19.70%452.7M35.35%420.4M31.34%1.49B32.05%412M31.05%387.9M
Cost of revenue -20.00%9.2M-11.76%7.5M71.12%39.7M10.39%8.5M83.61%11.2M139.58%11.5M84.78%8.5M62.24%23.2M87.80%7.7M45.24%6.1M
Gross profit 31.69%581M23.28%507.8M26.06%1.85B25.33%506.7M27.71%487.6M18.16%441.2M34.61%411.9M30.94%1.47B31.31%404.3M30.84%381.8M
Operating expense 17.82%433.1M5.31%402.5M19.41%1.45B18.44%356.4M17.82%346.4M15.34%367.6M26.18%382.2M33.48%1.22B23.37%300.9M18.88%294M
Selling and administrative expenses 9.11%242M0.16%243.1M17.92%887.6M19.68%218.9M9.61%204.2M21.33%221.8M20.93%242.7M29.04%752.7M16.87%182.9M20.50%186.3M
Research and development costs 31.07%191.1M14.27%159.4M21.82%565M16.53%137.5M32.03%142.2M7.28%145.8M36.50%139.5M41.36%463.8M35.01%118M16.18%107.7M
Operating profit 100.95%147.9M254.55%105.3M58.55%394.8M45.36%150.3M60.82%141.2M34.55%73.6M858.06%29.7M19.83%249M61.56%103.4M97.30%87.8M
Net non-operating interest income expense -49.7M-8,063.64%-89.8M35.21%-4.6M0.00%-1.1M8.33%-1.1M057.69%-1.1M72.48%-7.1M83.33%-1.1M81.82%-1.2M
Non-operating interest expense --49.7M8,063.64%89.8M-35.21%4.6M0.00%1.1M-8.33%1.1M--0-57.69%1.1M-72.48%7.1M-83.33%1.1M-81.82%1.2M
Other net income (expense) -99.17%400K114.40%19M-107.50%-58.1M214.10%49M-316.81%-24.5M163.32%48M-731.10%-131.9M65.26%-28M121.91%15.6M252.70%11.3M
Gain on sale of security -93.96%2.9M108.33%25M104.29%85.8M214.10%49M-316.81%-24.5M927.59%48M-42.58%12M70.04%42M-46.39%15.6M252.70%11.3M
Special income (charges) ---2.5M95.83%-6M-105.57%-143.9M--0--0--0---143.9M33.52%-70M--0--0
-Less:Other special charges --2.5M-95.83%6M105.57%143.9M--0----------143.9M-33.52%70M--0----
Income before tax -18.91%98.6M133.40%34.5M55.26%332.1M68.11%198.2M18.08%115.6M621.89%121.6M-582.71%-103.3M110.95%213.9M954.35%117.9M220.98%97.9M
Income tax 28.74%33.6M66.67%-8.9M38.72%82.4M74.74%50.5M10.54%32.5M507.81%26.1M-456.00%-26.7M403.39%59.4M544.62%28.9M267.50%29.4M
Net income -31.94%65M156.66%43.4M61.62%249.7M65.96%147.7M21.31%83.1M665.09%95.5M-651.08%-76.6M72.43%154.5M1,319.18%89M204.44%68.5M
Net income continuous Operations -31.94%65M156.66%43.4M61.62%249.7M65.96%147.7M21.31%83.1M665.09%95.5M-651.08%-76.6M72.43%154.5M1,319.18%89M204.44%68.5M
Minority interest income
Net income attributable to the parent company -31.94%65M156.66%43.4M61.62%249.7M65.96%147.7M21.31%83.1M665.09%95.5M-651.08%-76.6M72.43%154.5M1,319.18%89M204.44%68.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -31.94%65M156.66%43.4M61.62%249.7M65.96%147.7M21.31%83.1M665.09%95.5M-651.08%-76.6M72.43%154.5M1,319.18%89M204.44%68.5M
Basic earnings per share -34.69%0.64154.43%0.4359.01%2.5663.04%1.518.06%0.85644.44%0.98-626.67%-0.7969.47%1.611,250.00%0.92200.00%0.72
Diluted earnings per share -33.68%0.63153.16%0.4258.33%2.4763.64%1.4418.84%0.82627.78%0.95-664.29%-0.7969.57%1.561,200.00%0.88200.00%0.69
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg